Doxycycline Delayed-Release Tablets

Form: Doxycycline Delayed-Release Tablets

Strength: 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025

Reference Brands: Vibramycin (US & EU)

Category: Antibiotics

Doxycycline delayed-release tablets and capsules are approved in the EU and US for treating respiratory, urinary, and skin infections. In the EU, brands like Vibramycin XR are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for doxycycline XR formulations, ensuring adherence to European and US standards for safe, effective antibiotic therapy.